Deep learning as a staging tool in gastric cancer
- PMID: 32389797
- DOI: 10.1016/j.annonc.2020.04.477
Deep learning as a staging tool in gastric cancer
Conflict of interest statement
Disclosure Professor Cunningham has declared research funding from Amgen, Sanofi, Merrimack, AstraZeneca, Celgene, MedImmune, Bayer, 4SC, Clovis, Eli Lilly, Janssen, and Merck. He has participated in the Scientific Advisory Board of OVBIO. Dr De Paepe has declared no conflicts of interest.
Comment on
-
Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study.Ann Oncol. 2020 Jul;31(7):912-920. doi: 10.1016/j.annonc.2020.04.003. Epub 2020 Apr 15. Ann Oncol. 2020. PMID: 32304748
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
